Elanco Animal Health (ELAN) Cash & Current Investments (2017 - 2026)

Elanco Animal Health (ELAN) has 10 years of Cash & Current Investments data on file, last reported at $428.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments fell 12.11% year-over-year to $428.0 million; the trailing twelve-month figure through Mar 2026 stood at $428.0 million (down 12.11% YoY), and the FY2025 full-year result was $545.0 million, up 16.45% from the prior year.
• Cash & Current Investments retreated to $428.0 million in Q1 2026, from $545.0 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $545.0 million in Q4 2025 to a low of $318.0 million in Q1 2023.
• A 5-year average of $428.4 million and a median of $428.0 million in 2026 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments plunged 45.92% in 2022 and surged 41.16% in 2025, its largest moves.
• Tracing ELAN's Cash & Current Investments over 5 years: stood at $345.0 million in 2022, then increased by 2.03% to $352.0 million in 2023, then surged by 32.95% to $468.0 million in 2024, then climbed by 16.45% to $545.0 million in 2025, then declined by 21.47% to $428.0 million in 2026.
• Business Quant data shows ELAN's Cash & Current Investments at $428.0 million in Q1 2026, $545.0 million in Q4 2025, and $505.0 million in Q3 2025.